Anqi Lin - Search Results

Year	Number of Results
2016	1
2019	7
2020	20
2021	25
2022	25
2023	19
2024	8

1

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.

Zhou C, Peng S, Lin A, Jiang A, Peng Y, Gu T, Liu Z, Cheng Q, Zhang J, Luo P. Zhou C, et al. Among authors: lin a. EClinicalMedicine. 2023 Apr 21;59:101967. doi: 10.1016/j.eclinm.2023.101967. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37131541 Free PMC article.

2

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment.

Gao Z, Bai Y, Lin A, Jiang A, Zhou C, Cheng Q, Liu Z, Chen X, Zhang J, Luo P. Gao Z, et al. Among authors: lin a. Mol Cancer. 2023 Feb 15;22(1):31. doi: 10.1186/s12943-023-01722-0. Mol Cancer. 2023. PMID: 36793048 Free PMC article. Review.

3

Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.

Lin A, Zhang J, Luo P. Lin A, et al. Front Immunol. 2020 Aug 12;11:2039. doi: 10.3389/fimmu.2020.02039. eCollection 2020. Front Immunol. 2020. PMID: 32903444 Free PMC article.

4

Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.

Yang Q, Zhang H, Wei T, Lin A, Sun Y, Luo P, Zhang J. Yang Q, et al. Among authors: lin a. Front Immunol. 2021 Nov 5;12:756722. doi: 10.3389/fimmu.2021.756722. eCollection 2021. Front Immunol. 2021. PMID: 34804043 Free PMC article.

5

Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis.

Gu T, Jiang A, Zhou C, Lin A, Cheng Q, Liu Z, Zhang J, Luo P. Gu T, et al. Among authors: lin a. Int J Cancer. 2023 Feb 1;152(3):480-495. doi: 10.1002/ijc.34332. Epub 2022 Nov 3. Int J Cancer. 2023. PMID: 36274626 Free article.

6

Nanozyme-Enabled Analytical Chemistry.

Li S, Zhang Y, Wang Q, Lin A, Wei H. Li S, et al. Among authors: lin a. Anal Chem. 2022 Jan 11;94(1):312-323. doi: 10.1021/acs.analchem.1c04492. Epub 2021 Dec 6. Anal Chem. 2022. PMID: 34870985 No abstract available.

7

Microsphere-containing Hydrogel Scaffolds for Tissue Engineering.

Zhang S, Lin A, Tao Z, Fu Y, Xiao L, Ruan G, Li Y. Zhang S, et al. Among authors: lin a. Chem Asian J. 2022 Oct 17;17(20):e202200630. doi: 10.1002/asia.202200630. Epub 2022 Aug 16. Chem Asian J. 2022. PMID: 35909078 Review.

8

CTLs heterogeneity and plasticity: implications for cancer immunotherapy.

Peng S, Lin A, Jiang A, Zhang C, Zhang J, Cheng Q, Luo P, Bai Y. Peng S, et al. Among authors: lin a. Mol Cancer. 2024 Mar 21;23(1):58. doi: 10.1186/s12943-024-01972-6. Mol Cancer. 2024. PMID: 38515134 Free PMC article. Review.

9

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.

Shi C, Qin K, Lin A, Jiang A, Cheng Q, Liu Z, Zhang J, Luo P. Shi C, et al. Among authors: lin a. J Exp Clin Cancer Res. 2022 Sep 7;41(1):268. doi: 10.1186/s13046-022-02469-0. J Exp Clin Cancer Res. 2022. PMID: 36071479 Free PMC article. Review.

10

Self-Cascade Uricase/Catalase Mimics Alleviate Acute Gout.

Lin A, Sun Z, Xu X, Zhao S, Li J, Sun H, Wang Q, Jiang Q, Wei H, Shi D. Lin A, et al. Nano Lett. 2022 Jan 12;22(1):508-516. doi: 10.1021/acs.nanolett.1c04454. Epub 2021 Dec 30. Nano Lett. 2022. PMID: 34968071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year